abstract |
Antisense compounds, compositions, and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The composition comprises an antisense compound, in particular an antisense oligonucleotide, targeted to a nucleic acid encoding fibroblast growth factor receptor 4. Methods of using these compounds to modulate fibroblast growth factor receptor 4 expression and to treat diseases associated with the expression of fibroblast growth factor receptor 4 are provided. |